List of Tables
    Table 1. Key Players of Human Granulocyte Colony-stimulating Factor in Global Market
    Table 2. Top Human Granulocyte Colony-stimulating Factor Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Human Granulocyte Colony-stimulating Factor Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Human Granulocyte Colony-stimulating Factor Revenue Share by Companies, 2017-2022
    Table 5. Global Human Granulocyte Colony-stimulating Factor Sales by Companies, (K Units), 2017-2022
    Table 6. Global Human Granulocyte Colony-stimulating Factor Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Human Granulocyte Colony-stimulating Factor Price (2017-2022) & (US$/Unit)
    Table 8. Global Manufacturers Human Granulocyte Colony-stimulating Factor Product Type
    Table 9. List of Global Tier 1 Human Granulocyte Colony-stimulating Factor Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Human Granulocyte Colony-stimulating Factor Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Human Granulocyte Colony-stimulating Factor Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Human Granulocyte Colony-stimulating Factor Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Human Granulocyte Colony-stimulating Factor Sales (K Units), 2017-2022
    Table 15. By Type - Global Human Granulocyte Colony-stimulating Factor Sales (K Units), 2023-2028
    Table 16. By Application – Global Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Human Granulocyte Colony-stimulating Factor Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Human Granulocyte Colony-stimulating Factor Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Human Granulocyte Colony-stimulating Factor Sales (K Units), 2017-2022
    Table 20. By Application - Global Human Granulocyte Colony-stimulating Factor Sales (K Units), 2023-2028
    Table 21. By Region – Global Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Human Granulocyte Colony-stimulating Factor Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Human Granulocyte Colony-stimulating Factor Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Human Granulocyte Colony-stimulating Factor Sales (K Units), 2017-2022
    Table 25. By Region - Global Human Granulocyte Colony-stimulating Factor Sales (K Units), 2023-2028
    Table 26. By Country - North America Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2017-2022
    Table 29. By Country - North America Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2023-2028
    Table 38. By Country - South America Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2017-2022
    Table 41. By Country - South America Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales, (K Units), 2023-2028
    Table 46. Chugai Pharmaceutical Corporate Summary
    Table 47. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 48. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 49. Kyowa Hakko Kirin Corporate Summary
    Table 50. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 51. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 52. Sanway Corporate Summary
    Table 53. Sanway Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 54. Sanway Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 55. GenSci Corporate Summary
    Table 56. GenSci Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 57. GenSci Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 58. SL PHARM Corporate Summary
    Table 59. SL PHARM Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 60. SL PHARM Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 61. Kexing Bioproducts Corporate Summary
    Table 62. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 63. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 64. Qilu Pharmaceutical Corporate Summary
    Table 65. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 66. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 67. CSPC Corporate Summary
    Table 68. CSPC Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 69. CSPC Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 70. Wuzhong Pharmaceutical Corporate Summary
    Table 71. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 72. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 73. Quangang Pharmaceutical Corporate Summary
    Table 74. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 75. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 76. Huabei Pharmaceutical Corporate Summary
    Table 77. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 78. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 79. Harbin Pharmaceutical Corporate Summary
    Table 80. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 81. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 82. Amoytop Biotech Corporate Summary
    Table 83. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 84. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 85. Jiuyuan Gene Engineering Corporate Summary
    Table 86. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 87. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 88. Four Rings Biopharmaceutical Corporate Summary
    Table 89. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Product Offerings
    Table 90. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 91. Human Granulocyte Colony-stimulating Factor Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 92. Global Human Granulocyte Colony-stimulating Factor Capacity Market Share of Key Manufacturers, 2020-2022
    Table 93. Global Human Granulocyte Colony-stimulating Factor Production by Region, 2017-2022 (K Units)
    Table 94. Global Human Granulocyte Colony-stimulating Factor Production by Region, 2023-2028 (K Units)
    Table 95. Human Granulocyte Colony-stimulating Factor Market Opportunities & Trends in Global Market
    Table 96. Human Granulocyte Colony-stimulating Factor Market Drivers in Global Market
    Table 97. Human Granulocyte Colony-stimulating Factor Market Restraints in Global Market
    Table 98. Human Granulocyte Colony-stimulating Factor Raw Materials
    Table 99. Human Granulocyte Colony-stimulating Factor Raw Materials Suppliers in Global Market
    Table 100. Typical Human Granulocyte Colony-stimulating Factor Downstream
    Table 101. Human Granulocyte Colony-stimulating Factor Downstream Clients in Global Market
    Table 102. Human Granulocyte Colony-stimulating Factor Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Human Granulocyte Colony-stimulating Factor Segment by Type
    Figure 2. Human Granulocyte Colony-stimulating Factor Segment by Application
    Figure 3. Global Human Granulocyte Colony-stimulating Factor Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Human Granulocyte Colony-stimulating Factor Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Human Granulocyte Colony-stimulating Factor Revenue, 2017-2028 (US$, Mn)
    Figure 7. Human Granulocyte Colony-stimulating Factor Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Human Granulocyte Colony-stimulating Factor Revenue in 2021
    Figure 9. By Type - Global Human Granulocyte Colony-stimulating Factor Sales Market Share, 2017-2028
    Figure 10. By Type - Global Human Granulocyte Colony-stimulating Factor Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Human Granulocyte Colony-stimulating Factor Price (US$/Unit), 2017-2028
    Figure 12. By Application - Global Human Granulocyte Colony-stimulating Factor Sales Market Share, 2017-2028
    Figure 13. By Application - Global Human Granulocyte Colony-stimulating Factor Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Human Granulocyte Colony-stimulating Factor Price (US$/Unit), 2017-2028
    Figure 15. By Region - Global Human Granulocyte Colony-stimulating Factor Sales Market Share, 2017-2028
    Figure 16. By Region - Global Human Granulocyte Colony-stimulating Factor Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Human Granulocyte Colony-stimulating Factor Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Human Granulocyte Colony-stimulating Factor Sales Market Share, 2017-2028
    Figure 19. US Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Human Granulocyte Colony-stimulating Factor Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Human Granulocyte Colony-stimulating Factor Sales Market Share, 2017-2028
    Figure 24. Germany Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 25. France Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Human Granulocyte Colony-stimulating Factor Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Human Granulocyte Colony-stimulating Factor Sales Market Share, 2017-2028
    Figure 33. China Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 37. India Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Human Granulocyte Colony-stimulating Factor Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Human Granulocyte Colony-stimulating Factor Sales Market Share, 2017-2028
    Figure 40. Brazil Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share, 2017-2028
    Figure 44. Turkey Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Human Granulocyte Colony-stimulating Factor Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Human Granulocyte Colony-stimulating Factor Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Human Granulocyte Colony-stimulating Factor by Region, 2021 VS 2028
    Figure 50. Human Granulocyte Colony-stimulating Factor Industry Value Chain
    Figure 51. Marketing Channels